However, recent research has demonstrated that the loss of MAP2K3 copy number occurs in NSCLC and that MAP2K3 inhibits cell proliferation and promotes cellular senescence in hepatocellular carcinoma, breast cancer, and melanoma [7, 18, 19, 20, 21]. The gene discussed is MAP2K3; the disease is non-small cell lung carcinoma.